利用机器学习预测治疗双极性障碍患者的3个月缓解结果
Alessandro Cuomo1, Despoina Koukouna1, Simone Pardossi1
1Department of Molecular Medicine, School of Medicine, University of Siena, Siena, Italy.
Pharmacopsychiatry
|December 19, 2025
概括
机器学习准确地预测了双相情感障碍患者开始的3个月缓解期. 关键预测因素包括基线症状得分,肌素,TSH,BMI和年龄,使个性化治疗成为可能.
科学领域:
- 精神病学和计算神经科学
- 药物基因组学和个性化医学
背景情况:
- 是双相情感障碍的主要治疗方法,但并非所有患者都能达到完全缓解.
- 预测早期的治疗反应对于定制患者护理至关重要.
研究的目的:
- 开发和验证机器学习模型,用于预测开始治疗的双相情感障碍患者的3个月缓解期.
- 确定反应的关键临床和实验室预测因素.
主要方法:
- 分析了一组593名双相情感障碍患者的回顾性队列.
- 机器学习算法 (随机森林,XGBoost,神经网络,SVM) 用于根据基线数据预测缓解.
- 模型性能使用AUC和准确度与交叉验证进行评估.
主要成果:
- 三个月后整体缓解率为44%.
- 随机森林模型实现了最高的性能 (AUC=0.76,精度=0.64),超过了标准的物流模型.
- 重要的预测因素包括基线蒙哥马利-阿斯伯格抑郁症评分表和躁狂评分表得分,肌素,TSH,BMI和年龄.
结论:
- 机器学习,特别是渐变增强的树木,可以有效地预测治疗缓解双相情感障碍.
- 整合临床和实验室数据可以改善对治疗反应的早期识别.
- 这些发现支持双相情感障碍的个性化治疗策略.
相关概念视频
Mania and Antimanic Drugs: Overview
526
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
526
Bipolar Disorder
591
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
591
Psychosis: Goals of Pharmacotherapy
441
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
441


